Ocular Manifestations in Juvenile Behçet’s Disease: A Registry-Based Analysis from the AIDA Network

Introduction This study aims to characterize ocular manifestations of juvenile Behçet’s disease (jBD). Methods This was a registry-based observational prospective study. All subjects with jBD from the Autoinflammatory Diseases Alliance (AIDA) Network BD Registry showing ocular manifestations before...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ophthalmology and therapy 2024-06, Vol.13 (6), p.1479-1498
Hauptverfasser: Gaggiano, Carla, Tufan, Abdurrahman, Guerriero, Silvana, Ragab, Gaafar, Sota, Jurgen, Gentileschi, Stefano, Costi, Stefania, Almaghlouth, Ibrahim A., Hinojosa-Azaola, Andrea, Tharwat, Samar, Sfikakis, Petros P., Lopalco, Giuseppe, Piga, Matteo, Conti, Giovanni, Fragoulis, George, Mauro, Angela, Batu, Ezgi D., Ozen, Seza, Tarsia, Maria, La Torre, Francesco, Kawakami-Campos, Perla A., Vitale, Antonio, Caggiano, Valeria, Kardaş, Riza C., Tosi, Gian Marco, Frediani, Bruno, Avčin, Tadej, Hernández-Rodríguez, José, Cantarini, Luca, Fabiani, Claudia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction This study aims to characterize ocular manifestations of juvenile Behçet’s disease (jBD). Methods This was a registry-based observational prospective study. All subjects with jBD from the Autoinflammatory Diseases Alliance (AIDA) Network BD Registry showing ocular manifestations before 18 years were enrolled. Results We included 27 of 1000 subjects enrolled in the registry (66.7% male patients, 45 affected eyes). The median (interquartile range [IQR]) age at ocular involvement was 14.2 (4.7) years. Uveitis affected 91.1% of eyes (anterior 11.1%, posterior 40.0%, panuveitis 40.0%), retinal vasculitis 37.8% and other manifestations 19.8%. Later onset ( p  = 0.01) and male predominance ( p  = 0.04) characterized posterior involvement. Ocular complications occurred in 51.1% of eyes. Patients with complications had earlier onset ( p  
ISSN:2193-8245
2193-6528
DOI:10.1007/s40123-024-00916-z